Accepted for Publication: October 10, 2012.
Published Online: May 20, 2013. doi:10.1001/jamaneurol.2013.1425.
Acquisition of data: Friedman, Baker, Barsness, Merriam.
Analysis and interpretation of data: Friedman, Baker, Jensen, Craft, Merriam, Otto, Novotny, Vitiello.
Drafting of the manuscript: Friedman, Baker, Jensen, Barsness, Vitiello.
Critical revision of the manuscript for important intellectual content: Friedman, Baker, Borson, Jensen, Craft, Merriam, Otto, Novotny, Vitiello.
Statistical analysis: Friedman, Baker.
Obtained funding: Friedman, Baker, Vitiello.
Administrative, technical, and material support: Friedman, Baker, Jensen, Barsness, Craft, Merriam, Vitiello.
Study supervision: Friedman, Baker, Vitiello.
Conflict of Interest Disclosures: None reported.
Funding/Support: This project was supported by the National Institute on Aging, National Institutes of Health (grants R01 AG030484-01 [principal investigator, Dr Friedman] and AG025515 [principal investigator, Dr Vitiello]). A portion of this work was conducted through the Clinical Research Center Facility at the University of Washington Medical Center, which is supported by the National Center for Research Resources, National Institutes of Health (grant ULRR025014).
Previous Presentation: Presented in part at the Alzheimer’s Association International Conference; July 14-19, 2012; Vancouver, British Columbia, Canada.
Additional Contributions: Tesamorelin and placebo were donated for the study by Theratechnologies Inc. Jane Corkery-Hahn, MS, M. Ashley Heald, MA, and Monica Kletke, BS, assisted in conducting this research.